1 万璐冰,师志海,蔡沅滨,等.犬白内障病理模型的建立及药物治疗效果的观察[J].中国兽医杂志,2010,46(5):59~60. 2 王凤翔.糖性白内障[J].军医进修学院学报,1997,18(4):305~307. 3 王继红,刘学政,杨雪佳.尾静脉注射STZ制备1型糖尿病大鼠模型实验的技巧[J].辽宁医学院学报,2010,31(1):7~9. 4 刘亚平,季虹,荣海钦,等.不同性别大鼠在2 型糖尿病造模过程中的稳定性[J].中国实验动物学报,2008,16(1):52~55. 5 宋旭东,陈翠真.药物防治链脲佐菌素糖尿病性白内障的研究进展[J].国外眼科分册,2000,24(4):201~206. 6 李泽鸿,陶英楠,刘继阳,等. 6-羟基多巴胺致帕金森病大鼠模型的建立与评价[J].中国畜牧兽医,2012,39(12): 162~165. 7 林雯,谢茂松,徐国兴,等.水通道蛋白0,1在STZ-糖性白内障发病机制中的研究[J].福建医科大学学报,2009,43(6):452~455. 8 Hegde K R,Varma S D. Cataracts in experimentally diabetic mouse: Morphological and apoptotic changes[J]. Diabetes, Obesity and Metabolism 7,2005,7(2):200~204. 9 Kahn H A, Leibowitz H M, Ganley J P, et al. The framingham eye study.Ⅰ.Outline and major prevalence finding[J]. Am J Epidemiol,1977,106(1):17~32. 10 Kanth V R, Lavanya K,Srinivas J. Elevated expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats[J]. Current Eye Research,2009,34:274~281. 11 Pollreisz A, Schmidt-Erfurth U. Diabetic cataract——Pathogenesis,epidemiology and treatment[J]. Journal of Ophthalmology, 2010, 2010:17~25. 12 Randazzo J, Zhang P, Makita J, et al. Orally active multi-functional antioxidants delay cataract formation in streptozotocin (type 1) diabetic and Gamma-irradiated rats[J]. PLoS One,2011,6(4):e18980. 13 Shi Q, Yan H, Li M Y, et al. Effect of a combination of carnosine and aspirin eye drops on streptozotocin-induced diabetic cataract in rats[J]. Molecular Vision,2009,15:2129~2138. 14 Zhao W, Devamanoharan P S,Henein M, et al. Diabetes-induced biochemical changes in rat lens: Attenuation of cataractogenesis by pyruvate[J]. Diabetes, Obesity and Metabolism 2,2000,20(3):165~174. |